Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas. - Wikidata - awgldk - TriplyDB

Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas.

Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas.

http://www.wikidata.org/entity/Q40636451

about

Isolated limb perfusion with melphalan and TNF-alpha in the treatment of extremity sarcoma.Neoadjuvant and adjuvant chemotherapy with modified mesna, adriamycin, ifosfamide, and dacarbazine (MAID) regimen for adult high-grade non-small round cell soft tissue sarcomas.Phase I trial of preoperative chemoradiation plus sorafenib for high-risk extremity soft tissue sarcomas with dynamic contrast-enhanced MRI correlates.Radiographic response to neoadjuvant therapy and its impact on scope of surgery and prognosis in stage IIB/III soft tissue sarcomas.Epidemiology and therapies for metastatic sarcoma Surgical management of retroperitoneal and pelvic sarcomas.Surgical treatment of retroperitoneal liposarcoma.Retroperitoneal sarcomas- a challenging problem.Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study.Pleomorphous leiomyosarcoma of the mesocolon: a case report.Current concepts in multimodality therapy for retroperitoneal sarcoma.Neoadjuvant therapy followed by prostatectomy for clinically localized prostate cancer.Combined modalities approach for localized adult extremity soft-tissue sarcoma.Effectiveness of regional chemotherapy with TNF-alpha/melphalan in advanced soft tissue sarcoma of the extremities.Validation of radiographic response evaluation criteria of preoperative chemotherapy for bone and soft tissue sarcomas: Japanese Orthopaedic Association Committee on Musculoskeletal Tumors Cooperative Study Management of a catecholamine-secreting paraganglioma requiring aortic reconstruction.Role of chemotherapy in the management of soft tissue sarcomas.Current diagnosis and management of retroperitoneal sarcoma.Chemotherapy for osteosarcoma - where does it come from? What is it? Where is it going?Outcomes in the management of adult soft tissue sarcomas.Biopsy techniques for soft tissue and bowel sarcomas.Heparin regulates B6FS cell motility through a FAK/actin cytoskeleton axis Looking for answers: the current status of neoadjuvant treatment in localized soft tissue sarcomas.Practical Issues for Retroperitoneal Sarcoma.Low molecular weight heparin suppresses receptor for advanced glycation end products-mediated expression of malignant phenotype in human fibrosarcoma cells.Recurrence and survival analysis of resected soft tissue sarcomas of pelvic retroperitoneal structures.Can Abdominal Computed Tomography Imaging Help Accurately Identify a Dedifferentiated Component in a Well-Differentiated Liposarcoma?Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma.Size-based clinical response evaluation is insufficient to assess clinical response of sarcomas treated with isolated limb perfusion with TNF-α and melphalan.Predictors of surgical quality for retroperitoneal sarcoma: Volume matters.Diagnosis and treatment of soft-tissue sarcomas of the extremities and trunk.

P2860

Q33309291-F324A626-D6F5-4976-87CF-E28BF11FDA67 Q33398802-CC7B5D9E-7221-4C59-9FB5-3240A210CE1D Q33410972-5205C145-E532-447F-B20F-72DD89CFDBAD Q33641267-FD72494A-F3FB-4FD2-A2FE-68A9F667F8D4 Q34652142-2D6A7A4B-7EB8-437D-A716-5302F53695DE Q35224619-36D33950-5453-42F9-85A5-AFA2BB799CD0 Q35502750-4F24AA3B-15EB-4DE0-8B04-EC3E60082952 Q36240424-C153B4B9-EECD-4E39-BE2F-B3F44FB8AA25 Q36454797-813C6CD0-6868-4C5F-BB28-E616A1674E9B Q36626427-134FFA1B-B804-44A0-B8F9-63BDB8464AD4 Q36731422-7F371F26-FEC7-4693-8829-787D2C93D886 Q36973569-E6F3C6C8-9E6B-4844-A8B6-E3CF05DEE674 Q37008868-45E91B5D-6490-438C-95E0-8101556E8CB8 Q37130237-BD83D0CA-11AC-498D-A8C2-A3F32793E09F Q37426036-3D2FCF7A-500C-4032-9947-83EB4BE0BA2F Q37662615-4FC26F72-53C9-408D-9338-2716A23D2B1E Q37687389-5438D261-2EB5-4C02-85B0-C8A77B60F6BE Q37888460-E78C25D1-9FA2-4768-A92D-DF9B875C7AFF Q38126943-A0F666E8-C691-4CB1-8FA1-352977BC22A4 Q38223237-9749F65A-3021-4BB5-9D3E-B53AC322F82E Q38348576-72A06C16-93B4-42C4-A555-B351665AAB12 Q38737938-17972F9E-0D29-4C39-B057-3AAA1B34729F Q38840133-EF8E8E15-CF56-411A-BD1A-BF761E2402EB Q38936009-8D2F9BBB-867B-4132-A6F2-75D0847D6C29 Q39192067-C87B1604-A2E3-4C9A-A2CD-AADC9CF79CA8 Q40992002-8A292320-7B72-4729-B88F-18B074FA76DC Q42746834-A190BAA1-9920-4DD5-AE9B-3ED4F7F484B3 Q45133928-239353E3-47FC-45FD-9496-2CAA8A4E300E Q47308518-B6642686-DE3E-4D88-B724-9887944A78BA Q48287834-5DBDFD3C-16FA-44A8-BEC4-E35064E71ACB Q52418969-04F7F83C-1476-4AB2-90CF-2209DCF574A8

P2860

Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas.

http://www.wikidata.org/entity/Q40636451

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Radiographic response to neoad ...... vival in soft tissue sarcomas.

@en

type

label

Radiographic response to neoad ...... vival in soft tissue sarcomas.

@en

prefLabel

Radiographic response to neoad ...... vival in soft tissue sarcomas.

@en

P1433

Q40636451-DD1D53F6-CEC7-485F-8F27-76D0AE6A81A7

P1476

Q40636451-AD51B564-C479-4F03-B952-30A555395C1B

P2093

Q40636451-0B5C71C3-05ED-4F19-BA1A-64D991CDA47E

Q40636451-2936AC25-48E2-4203-8EFD-AA73861A5FE7

Q40636451-29BB99CA-71B7-4C75-8B8B-A5A070294390

Q40636451-3109AF42-A01F-4E02-B5DB-0E125C40A635

Q40636451-48803F15-CF17-42AC-BB06-A8C0288F9401

Q40636451-5AE0763B-52E7-4AAE-A5AD-56C1B184EED1

Q40636451-6180020A-DFF5-427F-8404-875161269EB3

Q40636451-671C1792-C5E2-43ED-9EBD-DE6C67A37377

Q40636451-7F2A4285-9829-418A-B499-7CE14F427ABF

Q40636451-8E26A295-D154-4674-A99E-50244EE61D15

P2860

Q40636451-1AFFB7AD-A6D5-473D-B1C7-D97A5001F01C

Q40636451-1F69E332-DAEC-4D2A-BF13-F18879289B5F

Q40636451-85B9E4D9-B14E-4382-9D03-5CED1DE2E2A6

Q40636451-BE32F157-91CD-45C3-9C48-41A73F6A9B5F

Q40636451-BF94493F-9723-4ACF-B1D1-7CBF7D0417BB

Q40636451-C4364936-5458-4D40-A806-DA82E49CD39B

Q40636451-EE145E31-E2AF-4213-88FD-C76345D6873B

P304

Q40636451-13C51F86-9D6A-41D3-9745-9D2227AACA3E

P31

Q40636451-B9E310A8-6929-4289-B4EF-220DC0E1DD2D

P356

Q40636451-E229CB55-A61A-479E-B44B-B476253617B8

P407

Q40636451-9C72241D-854D-4F16-A638-72080281FD15

P433

Q40636451-92B171C7-BFE0-4B07-9E0B-9BE5A143D02A

P478

Q40636451-7C89351D-7703-4CED-8968-5A67B60D977F

P577

Q40636451-E204DD85-9EFF-406D-9506-87EA33EE34FE

P5875

Q40636451-A066B729-C5E7-4876-9F6C-DBE67CC409A9

P698

Q40636451-5DEE08A5-BA2F-4C14-A36D-BDB956A814A3

P356

P1433

P1476

Radiographic response to neoad ...... vival in soft tissue sarcomas.

@en

P2093

Barry W Feig

http://www.w3.org/2001/XMLSchema#string

Carl Plager

http://www.w3.org/2001/XMLSchema#string

Datla G K Varma

http://www.w3.org/2001/XMLSchema#string

Funda Meric

http://www.w3.org/2001/XMLSchema#string

Kelly K Hunt

http://www.w3.org/2001/XMLSchema#string

Kenneth R Hess

http://www.w3.org/2001/XMLSchema#string

Kresimira M Milas

http://www.w3.org/2001/XMLSchema#string

Michael A Burgess

http://www.w3.org/2001/XMLSchema#string

Nicholas E J Papadopoulos

http://www.w3.org/2001/XMLSchema#string

Peter W T Pisters

http://www.w3.org/2001/XMLSchema#string

P2860

New chemotherapeutic strategies for soft tissue sarcomas.

Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas.

A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma.

Preoperative chemotherapy for stage IIIB extremity soft tissue sarcoma: long-term results from a single institution.

Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas.

CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size.

Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas.

P304

1120-1126

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.10794

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

2002-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11178726

http://www.w3.org/2001/XMLSchema#string

P698

12209699

http://www.w3.org/2001/XMLSchema#string